| Nu Skin Enterprises, Inc. | Key Financials | Relative to Peer Avg |
|---|---|---|
| Quarterly Revenue Growth | 18.68% | |
| Annual Revenue Growth | 61.26% | |
| Quarterly Net Income Growth | 13.49% | |
| Annual Net Income Growth | 109.18% | |
| Quarterly Free Cash Flow Growth | ||
| Total Debt Relative to Total Capital | 25.85% | |
| Operating Margin | 14.75% | |
| Return on Equity | 36.987% |
| Nu Skin Enterprises, Inc. (NUS) Dilution Analysis | |||
|---|---|---|---|
| Latest EPS | $0.9 | EPS Gain From Buy-back | $0.06 |
| Company | Revenue* | Net Income* | Rating | Sentiment |
|---|---|---|---|---|
| PG | 20,598.00 | 2,566.00 | Sign up to view | |
| KMB | 5,318.00 | 531.00 | Sign up to view | |
| CL | 4,315.00 | 460.00 | Sign up to view | |
| AVP | 2,483.70 | -13.70 | Sign up to view | |
| EL | 2,291.80 | 178.80 | Sign up to view | |
| CLX | 1,413.00 | 133.00 | Sign up to view | |
| MJN | 1,037.90 | 172.10 | Sign up to view | |
| CHD | 779.30 | 107.70 | Sign up to view | |
| NUS | 548.29 | 54.28 | Sign up to view | |
| REV | 331.90 | -6.90 | Sign up to view | |